Khisti R T, Chopde C T, Jain S P
Department of Pharmaceutical Sciences, Nagpur University Campus, 440 010, Maharashtra, Nagpur, India.
Pharmacol Biochem Behav. 2000 Sep;67(1):137-43. doi: 10.1016/s0091-3057(00)00300-2.
The present study aimed to examine the antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one (3alpha, 5alpha THP) using the forced swim test in mice. Intracerebroventricular (ICV, 1 or 2 microg/mouse) or intraperitoneal (IP, 0.5, 1, or 2 mg/kg) administration of 3alpha, 5alpha THP dose-dependently reduced the duration of immobility in forced swim test without accompanying changes in ambulatory or rearing behaviors in the open-field test. The antidepressant-like effect of 3alpha, 5alpha THP (1 microg/mouse, ICV) was potentiated by prior administration of the GABA(A) receptor agonist, muscimol (0. 5 mg/kg, IP) and blocked by prior administration of GABA(A) receptor antagonist, bicuculline (1 mg/kg, IP). Administration of the agonist at diazepam binding inhibitor receptors, 4'-chlorodiazepam (4'CD, 15 mg/kg, IP) or N,N-di-n-hexyl-2-(4-fluorophenyl)-indol-3-acetamide (FGIN 1-27, 1 or 2 microg/mouse, ICV), the 11beta-hydroxylase inhibitor, metyrapone (150 mg/kg, IP and 1 or 2 microg/mouse, ICV) and the selective serotonin reuptake inhibitor (SSRI), fluoxetine (20 mg/kg, IP), which are known to increase the endogenous level of neurosteroids, also reduced the duration of immobility in forced swim test. The tricyclic antidepressant, imipramine (20 mg/kg, IP), which does not increase the 3alpha, 5alpha THP in the brain, also reduced the immobility time. While the antidepressant-like effect of fluoxetine, which is known to selectively increase the brain content of 3alpha, 5alpha THP, was either blocked partially by bicuculline (1 mg/kg, IP) or potentiated by muscimol (0.5 mg/kg, IP), the antidepressant-like effect of imipramine was not modified by bicuculline. These results demonstrate the antidepressant-like effect of the neurosteroid 3alpha, 5alpha THP, and suggest further evaluation for its development as a new class of antidepressant drug.
本研究旨在通过小鼠强迫游泳试验检测神经甾体3α-羟基-5α-孕烷-20-酮(3α,5α-THP)的抗抑郁样作用。脑室内(ICV,1或2微克/小鼠)或腹腔内(IP,0.5、1或2毫克/千克)给予3α,5α-THP可剂量依赖性地缩短强迫游泳试验中的不动时间,且旷场试验中的自主活动或竖毛行为无伴随变化。3α,5α-THP(1微克/小鼠,ICV)的抗抑郁样作用在预先给予GABA(A)受体激动剂蝇蕈醇(0.5毫克/千克,IP)后增强,而在预先给予GABA(A)受体拮抗剂荷包牡丹碱(1毫克/千克,IP)后被阻断。给予地西泮结合抑制剂受体激动剂4'-氯地西泮(4'CD,15毫克/千克,IP)或N,N-二正己基-2-(4-氟苯基)-吲哚-3-乙酰胺(FGIN 1-27,1或2微克/小鼠,ICV)、11β-羟化酶抑制剂甲吡酮(150毫克/千克,IP和1或2微克/小鼠,ICV)以及已知可增加神经甾体内源性水平的选择性5-羟色胺再摄取抑制剂(SSRI)氟西汀(20毫克/千克,IP),也可缩短强迫游泳试验中的不动时间。三环类抗抑郁药丙咪嗪(20毫克/千克,IP)虽不增加脑中的3α,5α-THP,但也可缩短不动时间。虽然已知选择性增加脑内3α,5α-THP含量的氟西汀的抗抑郁样作用部分被荷包牡丹碱(1毫克/千克,IP)阻断或被蝇蕈醇(0.5毫克/千克,IP)增强,但丙咪嗪的抗抑郁样作用未被荷包牡丹碱改变。这些结果证明了神经甾体3α,5α-THP的抗抑郁样作用,并建议对其作为一类新型抗抑郁药物进行进一步评估。